For full functionality, including active links, we recommend downloading the PDF. Certain interactive features may not operate within the embedded viewer.
Download this PDF file

 

Crossref Citations

1. Comparison of the efficacy, safety and durability of a switch to co-formulated RPV/TDF-TAF/FTC or DTG/ABC/3TC in virologically-suppressed HIV-1-infected patients in a single Italian centre: a cohort data analysis
Filippo Lagi, Annarita Botta, Seble Tekle Kiros, Massimo Meli, Beatrice Borchi, Annalisa Cavallo, Marco Pozzi, Alessandro Bartoloni, Gaetana Sterrantino
International Journal of Antimicrobial Agents  vol: 59  issue: 1  first page: 106465  year: 2022  
doi: 10.1016/j.ijantimicag.2021.106465

2. Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022
Zhaoquan Wang, He Jiang, Xianwu Pang, Jianjun Li, Shujia Liang, Jinghua Huang, Dejian Li, Wenxuan Hou, Ni Chen, Guanghua Lan
Journal of Antimicrobial Chemotherapy  vol: 79  issue: 10  first page: 2575  year: 2024  
doi: 10.1093/jac/dkae260

3. Use of rilpivirine in HIV-1-infected individuals in routine clinical practice from 2012 to 2017 in France
Valérie Potard, Sebastien Gallien, Ana Canestri, Dominique Costagliola, S Abel, S Abgrall, C Allavena, H Bazus, A Becker, Benezit François, P Bouvet De La Maisonneuve, S Bregigeon, A Brugnon, F Caby, R Calin, A Cheret, D Costagliola, P De Truchis, B Denis, C Duvivier, P Enel, H Fischer, J Ghosn, M Goussef, S Grabar, F Huber, C Jacomet, V Joly, C Katlama, M A Khuong, A Makinson, L Marchand, G Martin-Blondel, S Matheron, J L Meynard, P Miailhes, M Nacher, E Piet, L Piroth, M Ploquin, V Rabier, O Robineau, E Rouveix Nordon, P Tattevin
Journal of Antimicrobial Chemotherapy  vol: 76  issue: 2  first page: 467  year: 2021  
doi: 10.1093/jac/dkaa449

4. The Meandrous Route of Rilpivirine in the Search for the Miraculous Drug to Treat HIV Infections
Erik De Clercq
Viruses  vol: 17  issue: 7  first page: 959  year: 2025  
doi: 10.3390/v17070959

5. Prognostic model for nephrotoxicity among HIV-positive Zambian adults receiving tenofovir disoproxil fumarate-based antiretroviral therapy
Freeman W. Chabala, Edward D. Siew, Wilbroad Mutale, Lloyd Mulenga, Aggrey Mweemba, Fastone Goma, Njeleka Banda, Patrick Kaonga, William C. Wester, Douglas C. Heimburger, Muktar H. Aliyu, Derick Munkombwe, Serena Maria Bagnasco
PLOS ONE  vol: 16  issue: 7  first page: e0252768  year: 2021  
doi: 10.1371/journal.pone.0252768